We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
AUM
$2.31B
AUM Growth
+$641M
Cap. Flow
+$372M
Cap. Flow %
16.15%
Top 10 Hldgs %
31.4%
Holding
680
New
190
Increased
323
Reduced
69
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 15.48%
3 Consumer Discretionary 11.83%
4 Financials 11.36%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UDR icon
601
UDR
UDR
$12.3B
$79K ﹤0.01%
1,727
WIX icon
602
WIX.com
WIX
$2.52B
$79K ﹤0.01%
657
-27
-4% -$2.93K
VNO icon
603
Vornado Realty Trust
VNO
$7.38B
$78K ﹤0.01%
1,151
WVE icon
604
Wave Life Sciences
WVE
$1.2B
$78K ﹤0.01%
2,001
+495
+33% +$20.1K
XRX icon
605
Xerox
XRX
$425M
$77K ﹤0.01%
2,423
-393
-14% -$11.1K
DBX icon
606
Dropbox
DBX
$8.12B
$75K ﹤0.01%
3,452
+196
+6% +$4.56K
ELLI
607
DELISTED
Ellie Mae Inc
ELLI
$75K ﹤0.01%
757
-19
-2% -$1.65K
AQST icon
608
Aquestive Therapeutics
AQST
$494M
$74K ﹤0.01%
+10,742
New +$75.3K
NUAN
609
DELISTED
Nuance Communications, Inc.
NUAN
$74K ﹤0.01%
5,077
+254
+5% +$3.52K
BAH icon
610
Booz Allen Hamilton
BAH
$9.15B
$72K ﹤0.01%
1,240
-975
-44% -$50.6K
FRT icon
611
Federal Realty Investment Trust
FRT
$10.3B
$72K ﹤0.01%
521
KALV
612
DELISTED
KalVista Pharmaceuticals
KALV
$72K ﹤0.01%
2,512
GDDY icon
613
GoDaddy
GDDY
$11.5B
$70K ﹤0.01%
933
+93
+11% +$6.54K
MDCO
614
DELISTED
Medicines Co
MDCO
$70K ﹤0.01%
2,517
IT icon
615
Gartner
IT
$11.7B
$69K ﹤0.01%
457
+33
+8% +$4.58K
ENV
616
DELISTED
ENVESTNET, INC.
ENV
$69K ﹤0.01%
1,060
+25
+2% +$1.44K
REG icon
617
Regency Centers
REG
$14.1B
$66K ﹤0.01%
974
BLKB icon
618
Blackbaud
BLKB
$2.08B
$64K ﹤0.01%
809
+97
+14% +$7.12K
REPL icon
619
Replimune Group
REPL
$1.01B
$63K ﹤0.01%
4,156
LNT icon
620
Alliant Energy
LNT
$18B
$62K ﹤0.01%
1,313
+136
+12% +$6.09K
CHRS icon
621
Coherus Oncology
CHRS
$196M
$61K ﹤0.01%
4,459
+1,053
+31% +$14K
ETR icon
622
Entergy
ETR
$50B
$61K ﹤0.01%
1,280
+110
+9% +$4.97K
NWSA icon
623
News Corp Class A
NWSA
$15.4B
$61K ﹤0.01%
4,916
+882
+22% +$11.1K
FOX icon
624
Fox Class B
FOX
$23.9B
$59K ﹤0.01%
+1,642
New +$62.6K
TWST icon
625
Twist Bioscience
TWST
$7.25B
$58K ﹤0.01%
2,513
-2,121
-46% -$47.9K

Similar funds

Tiverton Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Tiverton Asset Management held 680 positions worth $2.31B, up 38% from $1.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tiverton Asset Management deployed $372M of net new capital in Q1 2019, opening 190 new positions and adding to 323 existing holdings. Its largest new stake was Pfizer: 104,318 shares worth $4.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Celgene Corp, an estimated $7.15M trimmed.

  • Tiverton Asset Management's largest Q1 2019 buy was Pfizer: 104,318 shares worth $4.2M.
  • Tiverton Asset Management added most to Alphabet (Google) Class A in Q1 2019, an estimated $9.6M increase.
  • Tiverton Asset Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $7.15M.
  • Tiverton Asset Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $1.07M.
  • Tiverton Asset Management's ten largest holdings make up 31% of its $2.31B portfolio in Q1 2019.
  • Tiverton Asset Management opened 190 new positions and closed 28 in Q1 2019.
  • Tiverton Asset Management's portfolio value rose 38% quarter-over-quarter to $2.31B.

Based on Tiverton Asset Management's 13F filing for Q1 2019, filed 13 May 2019.